Antisense oligonucleotide strategies in physiology
- 31 May 1994
- journal article
- review article
- Published by Elsevier in Molecular and Cellular Endocrinology
- Vol. 101 (1-2), R15-R24
- https://doi.org/10.1016/0303-7207(94)90254-2
Abstract
No abstract availableKeywords
This publication has 59 references indexed in Scilit:
- Inhibition of RabSB expression attenuates Ca2+-dependent exocytosis in rat anterior pituitary cellsNature, 1993
- Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery.Journal of Clinical Investigation, 1993
- Administration of a Phosphorothioate Oligonucleotide Antisense to Murine Endogenous Retroviral MCF env Causes Immune Effects in Vivo in a Sequence-Specific MannerClinical Immunology and Immunopathology, 1993
- Prospects for gene-directed therapy with antisense oligodeoxynucleotidesCancer Treatment Reviews, 1993
- Modulation of human prorenin gene expression by antisense oligonucleotides in transfected CHO cellsEuropean Journal of Biochemistry, 1993
- Dialysis of lactotropes with antisense oligonucleotides assigns guanine nucleotide binding protein subtypes to their channel effectorsMolecular Endocrinology, 1992
- Complete protection of antisense oligonucleotides against serum nuclease degradation by an avidin-biotin systemBioconjugate Chemistry, 1992
- Rational design of sequence-specific oncogene inhibitors based on antisense and antigene oligonucleotidesEuropean Journal of Cancer and Clinical Oncology, 1991
- A novel method to modulate desensitization and truncation of luteinizing hormone receptors using antisense oligodeoxynucleotidesMolecular and Cellular Endocrinology, 1991
- Stability of antisense DNA oligodeoxynucleotide analogs in cellular extracts and seraLife Sciences, 1991